OpenURL Connection Search

Select item for more details and to access through your institution.

Zastosowanie narzędzia FRAX® do wyznaczania progu interwencji leczniczej osteoporozy w Polsce.
Published in:
Polish Archives of Internal Medicine, 2011, v. 121, n. 5, p. 155
By:
- Badurski, Janusz E.;
- Kanis, John A.;
- Johansson, Helena;
- Dobreñko, Andrzej;
- Nowak, Nonna A.;
- Daniluk, Stefan;
- Jeziernicka, Elzbieta
Publication type:
Article
The application of FRAX® to determine intervention thresholds in osteoporosis treatment in Poland.
Published in:
Polish Archives of Internal Medicine, 2011, v. 121, n. 5, p. 148, doi. 10.20452/pamw.1045
By:
- Badurski, Janusz E.;
- Kanis, John A.;
- Johansson, Helena;
- Dobreñko, Andrzej;
- Nowak, Nonna A.;
- Daniluk, Stefan;
- Jezienicka, Elzbieta
Publication type:
Article
The characteristics of osteoporotic fractures in the region of Bialystok (BOS-2). The application of the WHO algorithm, FRAX®BMI and FRAX®BMD assessment tools to determine patients for intervention.
Published in:
Polish Journal of Endocrinology / Endokrynologia Polska, 2011, v. 62, n. 4, p. 290
By:
- Badurski, Janusz;
- Jeziernicka, Elżbieta;
- Dobreńko, Andrzej;
- Nowak, Nonna;
- Daniluk, Stefan;
- Rybaczuk, Mikołaj;
- Wiś niowiecka, Magdalena
Publication type:
Article
Efficacy and Safety of Candidate Biosimilar CT-P43 Versus Originator Ustekinumab in Moderate to Severe Plaque Psoriasis: 28-Week Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study.
Published in:
BioDrugs, 2024, v. 38, n. 1, p. 121, doi. 10.1007/s40259-023-00630-5
By:
- Papp, Kim A.;
- Lebwohl, Mark G.;
- Thaçi, Diamant;
- Jaworski, Janusz;
- Kwiek, Bartlomiej;
- Trefler, Jakub;
- Dudek, Anna;
- Szepietowski, Jacek C.;
- Reznichenko, Nataliya;
- Narbutt, Joanna;
- Baran, Wojciech;
- Kolinek, Joanna;
- Daniluk, Stefan;
- Bartnicka-Maslowska, Katarzyna;
- Reich, Adam;
- Andrashko, Yuriy;
- Kim, Sunghyun;
- Bae, Yunju;
- Jeon, Dabee;
- Jung, Jinsun
Publication type:
Article

Found: 4

Zastosowanie narzędzia FRAX® do wyznaczania progu interwencji leczniczej osteoporozy w Polsce.

The application of FRAX® to determine intervention thresholds in osteoporosis treatment in Poland.

The characteristics of osteoporotic fractures in the region of Bialystok (BOS-2). The application of the WHO algorithm, FRAX®BMI and FRAX®BMD assessment tools to determine patients for intervention.

Efficacy and Safety of Candidate Biosimilar CT-P43 Versus Originator Ustekinumab in Moderate to Severe Plaque Psoriasis: 28-Week Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study.